Metal-organic Skeleton (MOF) Composite based Using Electrochemical Immunobiosensor to Detect the Important Tumor Marker of Breast Cancer Glycotype Antigen 15-3

Shuhuang Chen

doi:10.54097/ijbls.v4i1.17

Authors

Shuhuang Chen

DOI:

https://doi.org/10.54097/ijbls.v4i1.17

Keywords:

Metal-organic Skeleton (MOF), Biosensors, Breast Cancer, Sugar Antigens 15-3, Electrochemical Immunity

Abstract

Breast cancer is one of the biggest threats to women's life and health in the world, and the mortality rate has reached the second highest in the world. With the development of metal organic skeleton (MOF) and the advantages of the composite in the field of electrochemistry and biosensing, various metal organic skeleton composites have been widely used in electrochemical biosensors. Thus, electrochemical biosensors have received extensive attention and research in the field of rapid breast cancer detection. This article mainly introduces the detection of sugar-type important tumor marker antigen 15-3, and electrochemical immunobiosensor Excellent performance in breast cancer detection and promising prospects for its application.

Downloads

Download data is not yet available.

References

Fan, K., Zheng, Y., Li, D., et al. (2020) Research progress on electrochemical biosensor for breast cancer detection based on nanomaterials. Chinese Journal of Medical Devices, 44 (06): 525-531.

Zhang, H. (2019) Breast cancer detection based on deep learning. China New Communications, 21 (05): 207-208.

Chen, G. (2023) Serum CEA, CA15-3, CYFRA21-l and COX-2 combined test in breast cancer diagnosis. Modern diagnosis and treatment, 34 (07): 963-965

Tian, H., Wu, X., Gao, J. (2023) Study the application value of serum CA15-3 and HER-2 / neu in the diagnosis of benign and malignant breast diseases, Modern Diagnosis and Treatment, 59-60.

Rong, S., Zhang, H., Zou, L., et al (2020) Application progress of metal-organic framework composite biosensor to detect tumor markers.

Liu, J. (2022) Evaluation value of serum CEA, CA15-3, CA125 test on the chemotherapy effect of breast cancer. Clinical Medicine, 42(12): 70-72.

Hou, W. (2022) Expression level of serum CYFRA21-1, HCY and CA15-3 in breast cancer patients and diagnostic value for breast cancer. Application of modern drugs in China, 16(09):21-24

Zhang, W., Tang, R. (2023) The expression difference of serum CYFRA21-1, HCY and CA15-3 with different molecular types and the relationship between breast cancer and postoperative recurrence and metastasis. Laboratory medicine and clinical, 20 (12): 1686-1689.

Wang, R., Li, S., Meng, P., et al (2021) Research progress of MicroRNAs electrochemical biosensor in breast cancer detection. Chemical notification, 84(12):1274-1283.

Li, F., Du, L., Huo, L. (2018) Clinical significance of serum tumor markers and cytokines in breast cancer detection. Continuing Medical Education in China, 10 (34): 57-58.